WJPR Citation New

  All Since 2020
 Citation  8502  4519
 h-index  30  23
 i10-index  227  96

Login

Best Article Awards

World Journal of Pharmaceutical Research (WJPR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

CROHN’S DISEASE AND PREGNANCY- A RARE COEXISTENCE

Dr. Sonal Bhuyar*

Abstract

Inflammatory Bowel Disease (IBD) is the name for conditions that cause inflammation and ulceration of the digestive tract, including Crohn’s disease (CD) and Ulcerative colitis (UC). The incidence of CD in Asia is approximately 0.5 cases per 1, 00,000 persons1, which is much lower than that in the west. But the gap is bridging over the last two decades, probably due to the westernization of life styles and environmental factors. The coexistence of CD with pregnancy is rare. This disease affects women during their child- bearing years, with the peak age of onset between 15-30 years2. It has a slight female predisposition with female- to male ratio being 1.2:1[1] The severity and extent of the disease at the time of conception appears to influence the course of disease during pregnancy. They have a higher rate of adverse outcomes and should be followed as high risk pregnancy with close monitoring and counseling. In this case, the importance of preconceptional control of disease and continuation of medical treatment in a patient of CD with pregnancy to optimize her clinical course and neonatal outcome is highlighted.

Keywords: Crohn’s disease, pregnancy, successful outcome.


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More